Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Tarrant

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Schizophrenia Research|October 3, 1999
Specificity of developmental precursors to schizophrenia and affective disordersP B Jones, C J Tarrant
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 20, 1999
Precursors to schizophrenia: do biological markers have specificity?C J Tarrant, P B Jones
European Archives of Psychiatry and Clinical Neuroscience|January 12, 2001
Developmental precursors and biological markers for schizophrenia and affective disorders: specificity and public health implicationsP B Jones, C J Tarrant
British Medical Journal|October 14, 1978
African travelD L Child, V M Child, C J Tarrant
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1983
Antibody responses after immunization with polyvalent pneumococcal vaccine containing 10, 25, or 50 micrograms of 14 polysaccharide types per doseF R Cano, M V Querry, C J Tarrant, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1980
Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza virus vaccineM A Mufson, H E Krause, C J Tarrant, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Schizophrenia Research|October 3, 1999
Specificity of developmental precursors to schizophrenia and affective disordersP B Jones, C J Tarrant
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 20, 1999
Precursors to schizophrenia: do biological markers have specificity?C J Tarrant, P B Jones
European Archives of Psychiatry and Clinical Neuroscience|January 12, 2001
Developmental precursors and biological markers for schizophrenia and affective disorders: specificity and public health implicationsP B Jones, C J Tarrant
British Medical Journal|October 14, 1978
African travelD L Child, V M Child, C J Tarrant
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1983
Antibody responses after immunization with polyvalent pneumococcal vaccine containing 10, 25, or 50 micrograms of 14 polysaccharide types per doseF R Cano, M V Querry, C J Tarrant, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1980
Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza virus vaccineM A Mufson, H E Krause, C J Tarrant, et al.
Pageof 1